查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
抗体治疗市场- 按类型[单株抗体(mAb) {肿瘤、自体免疫疾病、传染病}、抗体药物偶联物(ADC)]、按最终用途（医院、专科中心）划分- 全球预测，2023年- 2032 年
市场调查报告书
商品编码
1416204

抗体治疗市场- 按类型[单株抗体(mAb) {肿瘤、自体免疫疾病、传染病}、抗体药物偶联物(ADC)]、按最终用途（医院、专科中心）划分- 全球预测，2023年- 2032 年

Antibody Therapy Market - By Type [Monoclonal Antibodies (mAbs) {Oncology, Autoimmune Disease, Infectious Disease}, Antibody-drug Conjugates (ADCs)], By End-use (Hospitals, Specialty Centers) - Global Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

预计从 2023 年到 2032 年，抗体治疗市场规模将以 11.8% 的CAGR扩大。癌症和自体免疫疾病等慢性疾病的盛行率不断上升，刺激了对多种针对性和个人化治疗的需求。

生物技术和免疫学的不断进步正在鼓励新型且更有效的抗体疗法的开发。例如，2023 年 9 月，Manaolana Oncology Inc. 透过德州大学 MD 安德森癌症中心和 Panacea Venture 之间的合作正式成立，旨在开发和推进针对新兴癌症抗原的基于抗体的疗法。此外，人们越来越意识到抗体疗法的好处，包括减少副作用和改善治疗结果，这将增加他们的需求。抗体药物研发投入的增加以及各医疗领域应用范围的扩大将进一步推动市场扩张。

抗体治疗行业按类型、最终用途和地区划分。

预计从 2023 年到 2032 年，抗体药物偶联物领域的市场份额将以 11.6% 的CAGR增长。这主要是由于研发活动的增加、癌症患病率的上升以及生物技术的突飞猛进。对标靶和个人化治疗的高需求也将推动该细分市场的成长。

预计 2023 年至 2032 年间，专科中心最终用途领域的抗体治疗市场份额将以 12.5% 的CAGR增长。这一增长可归因于慢性病患病率的不断上升、寻求专业护理的患者群体的扩大以及医疗技术的不断进步。精准医疗。此外，专科中心在提供标靶治疗方面发挥着至关重要的作用，推动了抗体疗法在这些中心的采用。

从地区来看，由于慢性病盛行率不断上升以及生物製药研发投资不断增加，欧洲抗体治疗市场规模预计从2023年到2032年将以11.6%的成长率扩大。此外，对个人化医疗的认识不断增强，以及有利的监管环境的存在，将刺激整个地区对抗体疗法的需求。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：抗体治疗产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 全球慢性和传染病患者病率不断上升
      • 不断成长的研发活动
      • 在美国和欧洲的高采用率和批准率
      • 蓬勃发展的生物製品产业
      • 抗体疗法的应用不断增加
    • 产业陷阱与挑战
      • 一些单株抗体疗法的成本较高
      • 复杂的製造流程与物流挑战
  • 成长潜力分析
  • COVID-19 影响分析
  • 管道产品
    • 单株抗体
    • 抗体药物偶联物
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 公司定位矩阵
  • 战略展望矩阵

第 5 章：抗体治疗市场规模与预测：按类型，2018-2032

  • 主要动向：依类型
  • 单株抗体 (mAb)
    • 肿瘤学
    • 自体免疫疾病
    • 传染性疾病
    • 其他单株抗体 (mAb)
  • 抗体药物偶联物 (ADC)

第 6 章：抗体治疗市场规模与预测：依最终用途分类，2018-2032 年

  • 主要动向：依最终用途
  • 医院
  • 专科中心
  • 其他最终用户

第 7 章：抗体治疗市场规模及预测：按地区划分，2018-2032

  • 主要动向：按地区
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 新加坡
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 科威特
    • 埃及
    • 中东和非洲其他地区

第 8 章：公司简介

  • F. Hoffmann-La Roche Ltd.
  • AbbVie, Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services, Inc.
  • Seagen
  • Merck & Co., Inc.
  • Regeneron Pharmaceuticals Inc.
  • Novartis AG
  • AstraZeneca
  • Eli Lilly and Company
  • GlaxoSmithKline plc.
  • Takeda Pharmaceutical Company Ltd.
Product Code: 5195

Antibody therapy market size is projected to expand at 11.8% CAGR from 2023 to 2032. The increasing prevalence of chronic diseases, such as cancer and autoimmune disorders, is fueling the demand for several targeted and personalized treatments.

The increasing advancements in biotechnology and immunology are encouraging the development of novel and more effective antibody therapies. For instance, in September 2023, Manaolana Oncology Inc. was officially launched through a collaboration between The University of Texas MD Anderson Cancer Center and Panacea Venture to develop and advance in antibody-based therapies for targeting the emerging cancer antigens. Additionally, the growing awareness of the benefits of antibody therapy, including reduced side effects and improved treatment outcomes will escalate their demand. The rising investments in R&D activities for antibody-based drugs and the expanding application scope in various medical fields will further drive the market expansion.

The antibody therapy industry is segregated into type, end-use, and region.

The market share from the antibody-drug conjugates segment is estimated to rise at 11.6% CAGR from 2023 to 2032. This is mainly on account of the increasing research and development activities, the rising prevalence of cancer, and the surging advancements in biotechnology. High demand for targeted and personalized therapies will also drive the segment growth.

Antibody therapy market share from the specialty centers end-use segment is projected to rise at 12.5% CAGR between 2023 and 2032. The growth can be attributed to the growing prevalence of chronic diseases, expanding patient pool seeking specialized care, and the rising advancements in precision medicine. Moreover, specialty centers play a crucial role in delivering targeted treatments, driving the adoption of antibody therapies in these centers.

Regionally, the Europe antibody therapy market size is projected to expand at 11.6% growth rate from 2023 and 2032, due to the increasing prevalence of chronic diseases and the rising biopharmaceutical R&D investments. Furthermore, the growing awareness about personalized medicine, and the presence of favorable regulatory environment will fuel the demand for antibody therapies across the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & workings
    • 1.2.1 Data collection
  • 1.3 Forecast calculations
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Antibody therapy market 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Type trends
    • 2.1.4 End-use trends

Chapter 3 Antibody Therapy Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic and infectious disease worldwide
      • 3.2.1.2 Growing R&D activities
      • 3.2.1.3 High rate of adoption and approval in the U.S. and Europe
      • 3.2.1.4 Booming biologics industry
      • 3.2.1.5 Rising applications of antibody therapy
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of some monoclonal antibody therapeutics
      • 3.2.2.2 Complex manufacturing processes and logistical challenges
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By end-use
  • 3.4 COVID- 19 impact analysis
  • 3.5 Pipeline products
    • 3.5.1 Monoclonal antibodies
    • 3.5.2 Antibody drug conjugates
  • 3.6 Regulatory landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company market share analysis, 2022
  • 4.3 Competitive analysis of major market players, 2022
  • 4.4 Company positioning matrix, 2022
  • 4.5 Strategy outlook matrix, 2022

Chapter 5 Antibody Therapy Market Size and Forecast, By Type, 2018-2032 (USD Million)

  • 5.1 Key trends, by type
  • 5.2 Monoclonal antibodies (mAbs)
    • 5.2.1 Oncology
    • 5.2.2 Autoimmune diseases
    • 5.2.3 Infectious diseases
    • 5.2.4 Other monoclonal antibodies (mAbs)
  • 5.3 Antibody-drug conjugates (ADCs)

Chapter 6 Antibody Therapy Market Size and Forecast, By End-use, 2018-2032 (USD Million)

  • 6.1 Key trends, by end-use
  • 6.2 Hospitals
  • 6.3 Specialty centers
  • 6.4 Other end-users

Chapter 7 Antibody Therapy Market Size and Forecast, By Region, 2018-2032 (USD Million)

  • 7.1 Key trends, by region
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 Singapore
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East & Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Kuwait
    • 7.6.5 Egypt
    • 7.6.6 Rest of Middle East & Africa

Chapter 8 Company Profiles

  • 8.1 F. Hoffmann-La Roche Ltd.
  • 8.2 AbbVie, Inc.
  • 8.3 Amgen Inc.
  • 8.4 Bristol-Myers Squibb Company
  • 8.5 Johnson & Johnson Services, Inc.
  • 8.6 Seagen
  • 8.7 Merck & Co., Inc.
  • 8.8 Regeneron Pharmaceuticals Inc.
  • 8.9 Novartis AG
  • 8.10 AstraZeneca
  • 8.11 Eli Lilly and Company
  • 8.12 GlaxoSmithKline plc.
  • 8.13 Takeda Pharmaceutical Company Ltd.

Data Tables

  • TABLE 1 Market revenue, by type (2022)
  • TABLE 2 Market revenue, by end-use (2022)
  • TABLE 3 Market share, by region (2022)
  • TABLE 4 Global antibody therapy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 5 Global antibody therapy market size, by region, 2023 - 2032 (USD Million)
  • TABLE 6 Global antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 7 Global antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 8 Global antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 9 Global antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 10 Industry impact forces
  • TABLE 11 Monoclonal antibodies (mAb) market size, 2018 - 2022 (USD Million)
  • TABLE 12 Monoclonal antibodies (mAb) market size, 2023 - 2032 (USD Million)
  • TABLE 13 Oncology market size, 2018 - 2022 (USD Million)
  • TABLE 14 Oncology market size, 2018 - 2022 (USD Million)
  • TABLE 15 Autoimmune diseases market size, 2023 - 2032 (USD Million)
  • TABLE 16 Autoimmune diseases market size, 2018 - 2022 (USD Million)
  • TABLE 17 Infectious diseases market size, 2018 - 2022 (USD Million)
  • TABLE 18 Infectious diseases market size, 2023 - 2032 (USD Million)
  • TABLE 19 Other monoclonal antibodies (mAbs) market size, 2023 - 2032 (USD Million)
  • TABLE 20 Other monoclonal antibodies (mAbs) market size, 2018 - 2022 (USD Million)
  • TABLE 21 Antibody-drug conjugates (ADCs) market size, 2023 - 2032 (USD Million)
  • TABLE 22 Antibody-drug conjugates (ADCs) market size, 2018 - 2022 (USD Million)
  • TABLE 23 North America antibody therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 24 North America antibody therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 25 North America antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 26 North America antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 27 North America antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 28 North America antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 29 North America antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 30 North America antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 31 U.S. antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 32 U.S. antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 33 U.S. antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 34 U.S. antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 35 U.S. antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 36 U.S. antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 37 Canada antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 38 Canada antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 39 Canada antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 40 Canada antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 41 Canada antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 42 Canada antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 43 Europe antibody therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 44 Europe antibody therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 45 Europe antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 46 Europe antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 47 Europe antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 48 Europe antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 49 Europe antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 50 Europe antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 51 Germany antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 52 Germany antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 53 Germany antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 54 Germany antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 55 Germany antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 56 Germany antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 57 UK antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 58 UK antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 59 UK antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 60 UK antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 61 UK antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 62 UK antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 63 France antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 64 France antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 65 France antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 66 France antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 67 France antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 68 France antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 69 Spain antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 70 Spain antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 71 Spain antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 72 Spain antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 73 Spain antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 74 Spain antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 75 Italy antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 76 Italy antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 77 Italy antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 78 Italy antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 79 Italy antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 80 Italy antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 81 Rest of Europe antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 82 Rest of Europe antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 83 Rest of Europe antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 84 Rest of Europe antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 85 Rest of Europe antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 86 Rest of Europe antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 87 Asia Pacific antibody therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 88 Asia Pacific antibody therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 89 Asia Pacific antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 90 Asia Pacific antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 91 Asia Pacific antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 92 Asia Pacific antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 93 Asia Pacific antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 94 Asia Pacific antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 95 China antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 96 China antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 97 China antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 98 China antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 99 China antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 100 China antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 101 Japan antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 102 Japan antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 103 Japan antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 104 Japan antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 105 Japan antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 106 Japan antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 107 India antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 108 India antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 109 India antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 110 India antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 111 India antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 112 India antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 113 Australia antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 114 Australia antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 115 Australia antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 116 Australia antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 117 Australia antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 118 Australia antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 119 Singapore antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 120 Singapore antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 121 Singapore antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 122 Singapore antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 123 Singapore antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 124 Singapore antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 125 Rest of Asia Pacific antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 126 Rest of Asia Pacific antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 127 Rest of Asia Pacific antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 128 Rest of Asia Pacific antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 129 Rest of Asia Pacific antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 130 Rest of Asia Pacific antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 131 Latin America antibody therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 132 Latin America antibody therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 133 Latin America antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 134 Latin America antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 135 Latin America antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 136 Latin America antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 137 Latin America antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 138 Latin America antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 139 Brazil antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 140 Brazil antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 141 Brazil antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 142 Brazil antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 143 Brazil antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 144 Brazil antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 145 Mexico antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 146 Mexico antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 147 Mexico antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 148 Mexico antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 149 Mexico antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 150 Mexico antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 151 Argentina antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 152 Argentina antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 153 Argentina antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 154 Argentina antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 155 Argentina antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 156 Argentina antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 157 Rest of Latin America antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 158 Rest of Latin America antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 159 Rest of Latin America antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 160 Rest of Latin America antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 161 Rest of Latin America antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 162 Rest of Latin America antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 163 Middle East & Africa antibody therapy market size, By country, 2018 - 2022 (USD Million)
  • TABLE 164 Middle East & Africa antibody therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 165 Middle East & Africa antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 166 Middle East & Africa antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 167 Middle East & Africa antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 168 Middle East & Africa antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 169 Middle East & Africa antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 170 Middle East & Africa antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 171 South Africa antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 172 South Africa antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 173 South Africa antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 174 South Africa antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 175 South Africa antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 176 South Africa antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 177 Saudi Arabia antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 178 Saudi Arabia antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 179 Saudi Arabia antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 180 Saudi Arabia antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 181 Saudi Arabia antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 182 Saudi Arabia antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 183 UAE antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 184 UAE antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 185 UAE antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 186 UAE antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 187 UAE antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 188 UAE antibody therapy market size, by end-use, 2023 - 2032 (USD Million) Saudi Arabia antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 189 Kuwait antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 190 Kuwait antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 191 Kuwait antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 192 Kuwait antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 193 Kuwait antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 194 Egypt antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 195 Egypt antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 196 Egypt antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 197 Egypt antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 198 Egypt antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 199 Egypt antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 200 Rest of Middle East & Africa antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 201 Rest of Middle East & Africa antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 202 Rest of Middle East & Africa antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 203 Rest of Middle East & Africa antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 204 Rest of Middle East & Africa antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 205 Rest of Middle East & Africa antibody therapy market size, by end-use, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Antibody therapy industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by type
  • FIG 8 Growth potential analysis, by end-use
  • FIG 9 Porter's analysis
  • FIG 10 PESTEL analysis
  • FIG 11 Company matrix analysis, 2022
  • FIG 12 Competitive analysis of major market players, 2022
  • FIG 13 Competitive positioning matrix, 2022
  • FIG 14 Strategic dashboard, 2022